Public webinar series | Supporting HTA/Payer decision-making: Health data initiatives in Germany
On 21 September 2022, the RWE4Decisions community gathered for a multi-stakeholder discussion on HealthData in Germany, with a focus on the routine data collection practice (AbD) at the Federal Joint Committee (G-BA). The panel featured representation of HTA bodies, patients, insurers and industry.
Public Webinar Series | Supporting HTA/Payer decisions making: National health data initiatives in Finland, Spain and France
On 21 September 2022, the RWE4Decisions community gathered for a multi-stakeholder discussion on HealthData in Germany, with a focus on the routine data collection practice (AbD) at the Federal Joint Committee (G-BA). The panel featured representation of HTA bodies, patients, insurers and industry.
Towards Establishing an EU Real-World Evidence Generation Action Plan for Better Healthcare Systems & Patient Outcomes
The need for an EU Real-World Evidence (RWE) Generation Action Plan was a key conclusion from the 2020 RWE4Decisions Conference held under the auspices of the German EU Presidency. This call was taken up in the June EPSCO Council Conclusions on Access to Medicines under the Portuguese EU Presidency.
The Use of Real-World Evidence for Decision-Making: Next Steps to Develop HTA Guidance
In this webinar organized by the RWE4Decisions multi-stakeholder initiative, consideration will be given to methodological recommendations on generation and use of real-world evidence (RWE) in pricing and reimbursement decision-making with a view to identifying what steps need to be taken to align on the way forwards. Guidance can act as a roadmap to generate high-quality RWE, […]
Delivering a Health Data Strategy for the European Reference Networks
Since their inception in 2017, European Reference Networks (ERNs) have started building-up the evidence base for the natural history of rare diseases, starting with ERN registries and disease specific health outcomes. However, the full potential of ERNs can only be realised if they are able to combine and link different types of data from different sources, […]
Co-Creating RWE Excellence for Decision-Making: Meeting Regulatory and HTA/Payer Needs
In the first webinar – held on 22 April 2021 – we discussed the implications of the EMA’s Guidelines across the HTA/Payer world on study designs, methodologies and for the future applicability of RWE requirements. Consideration was also given to whether cross-country and cross-stakeholder collaboration should aim to achieve convergence of guidelines, metrics and methodologies […]
RWE4Decisions Symposium: Policies & Partnerships
RWE4Decisions hosted its annual Symposium on 24 November to conclude a year rich with learnings and reflect on the work plan for 2023.
Health Innovation – the European Health Data Space and Real-World Evidence
This conference considered how a multi-stakeholder EU Learning Network could be established to foster learnings from the use of real-world evidence within the context of the European Health Data Space in order to inform deliberations between payers/HTA authorities and enable a learning system to bring the right treatment, for the right patient, at the right […]
Realising the Potential of Real-World Evidence for Learning Healthcare Systems
The RWE4Decisions initiative held its first public meeting on 22 September to discuss how to support the use of real-world evidence to inform HTA/payer decisions and enable ‘learning healthcare systems’ to improve patient outcomes.